The Role of Gut Microbiota in the Progression of Parkinson’s Disease and the Mechanism of Intervention by Traditional Chinese Medicine

References

• Damier P, Hirsch EC, Agid Y, et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain. 1999;122:1437–1448. doi:10.1093/brain/122.8.1437
   PubMed Web of Science ®Google Scholar
• de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology. 2000;54:21–23.
   PubMed Web of Science ®Google Scholar
• Isaacson SH, Hauser RA. Improving symptom control in early Parkinson’s disease. Ther Adv Neurol Disord. 2009;2:393–400. doi:10.1177/1756285609339383
   Google Scholar
• Fahn S, Oakes D, Shoulson I, et al. Levodopa and the progression of Parkinson’s disease. N Engl J Med. 2004;351:2498–2508.
   PubMed Web of Science ®Google Scholar
• Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362:2077–2091. doi:10.1056/NEJMoa0907083
   PubMed Web of Science ®Google Scholar
• Liu B, Piao X, Niu W, et al. Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K/AKT/NF-κB oxidative and inflammatory signaling and gut microbiota. Front Pharmacol. 2020;11:1036. doi:10.3389/fphar.2020.01036
   PubMed Web of Science ®Google Scholar
• Ma ZJ, Wang HJ, Ma XJ, et al. Modulation of gut microbiota and intestinal barrier function during alleviation of antibiotic-associated diarrhea with Rhizoma Zingiber officinale (Ginger) extract. Food Funct. 2020;11(12):10839–10851. doi:10.1039/D0FO01536A
   Web of Science ®Google Scholar
• Sheng YA, Chao S, Yi J, et al. Herbal medicine WangShiBaoChiWan improves gastrointestinal health in mice via modulation of intestinal tight junctions and gut microbiota and inhibition of inflammation. Biomed Pharmacother. 2021;138:11426.
   Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821
   PubMed Web of Science ®Google Scholar
• Heinzel S, Aho VTE, Suenkel U, et al. Gut microbiome signatures of risk and prodromal markers of Parkinson disease. Ann Neurol. 2020;88(2):320–331. doi:10.1002/ana.25788
   PubMed Web of Science ®Google Scholar
• Heianza Y, Ma W, Manson JE, et al. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc. 2017;6(7):e004947. doi:10.1161/JAHA.116.004947
   PubMed Web of Science ®Google Scholar
• Hasegawa S, Goto S, Tsuji H, et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease. PLoS One. 2015;11:1–15.
   Google Scholar
• Keshavarzian A, Green J, Engen PA, et al. Colonic bacterial composition in Parkinson’s disease. Mov Disord. 2015;30:1351–1360. doi:10.1002/mds.26307
   PubMed Web of Science ®Google Scholar
• Qian YW, Yang XD, Xu SQ, et al. Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease. Brain Behav Immun. 2018;5:194–202. doi:10.1016/j.bbi.2018.02.016
   Web of Science ®Google Scholar
• Cirstea MS, Yu AC, Golz E, et al. Microbiota composition and metabolism are associated with gut function in Parkinson’s disease. Mov Disorders. 2020;35:1695–1697. doi:10.1002/mds.28208
   Web of Science ®Google Scholar
• Nishiwaki H, Ito M, Ishida T, et al. Meta-analysis of gut dysbiosis in Parkinson’s disease. Mov Disord. 2020;35:1626–1635. doi:10.1002/mds.28119
   PubMed Web of Science ®Google Scholar
• Wallen ZD, Appah M, Dean MN, et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis. 2020;6:11. doi:10.1038/s41531-020-0112-6
   PubMed Web of Science ®Google Scholar
• Li X, Yang W, Li X, et al. Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys. Neurosci Lett. 2018;662:276–282. doi:10.1016/j.neulet.2017.10.047
   Web of Science ®Google Scholar
• Braak H, Rüb U, Gai P, et al. Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110:517–536. doi:10.1007/s00702-002-0808-2
   PubMed Web of Science ®Google Scholar
• Ahn EH, Kang SS, Liu X, et al. Initiation of Parkinson’s disease from gut to brain by δ-secretase. Cell Res. 2020;30(1):70–87. doi:10.1038/s41422-019-0241-9
   PubMed Web of Science ®Google Scholar
• Phillips RJ, Walter GC, Wilder SL, et al. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson’s disease? Neuroscience. 2008;153:733–750. doi:10.1016/j.neuroscience.2008.02.074
   PubMed Web of Science ®Google Scholar
• Svensson E, Horváth-Puhó E, Thomsen RW, et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78:522–529. doi:10.1002/ana.24448
   PubMed Web of Science ®Google Scholar
• Francisco PM, Oleg A, Yanina D, et al. Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One. 2010;5:e8762. doi:10.1371/journal.pone.0008762
   Web of Science ®Google Scholar
• Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805–820. doi:10.1007/s00401-014-1343-6
   PubMed Web of Science ®Google Scholar
• Qin XY, Zhang SP, Cao C, et al. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2016;7311:1–9.
   Google Scholar
• Sampson TR, Debeliusm JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinsons’s disease. Cell. 2016;167:1469–1480. doi:10.1016/j.cell.2016.11.018
   PubMed Web of Science ®Google Scholar
• Daniele SG, Béraud D, Davenport C, et al. Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders. Sci Signal. 2015;8(376):ra45. doi:10.1126/scisignal.2005965
   PubMed Web of Science ®Google Scholar
• Girotti M, Donegan JJ, Morilak DA. Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology. 2013;38:1158–1169. doi:10.1016/j.psyneuen.2012.11.004
   PubMed Web of Science ®Google Scholar
• Matsuwaki T, Eskilsson A, Kugelberg U, et al. Interleukin-1β induced activation of the hypothalamus-pituitary-adrenal axis is dependent on interleukin-1 receptors on non-hematopoietic cells. Brain Behav Immun. 2014;40:166–173. doi:10.1016/j.bbi.2014.03.015
   Web of Science ®Google Scholar
• Galley JD, Nelson MC, Yu ZT, et al. Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol. 2014;14:189. doi:10.1186/1471-2180-14-189
   PubMed Web of Science ®Google Scholar
• Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;4(174):307–311. doi:10.1192/bjp.174.4.307
   Web of Science ®Google Scholar
• Enomoto S, Shimizu K, Nibuya M, et al. Increased expression of endocytosis-Related proteins in rat hippocampus following 10-day electroconvulsive seizure treatment. Neurosci Lett. 2016;624:85–91. doi:10.1016/j.neulet.2016.05.015
   Web of Science ®Google Scholar
• Tuon T, Valvassori SS, Dal Pont GC, et al. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson’s disease. Brain Res Bull. 2014;108:106–112. doi:10.1016/j.brainresbull.2014.09.006
   PubMed Web of Science ®Google Scholar
• Ait-Belgnaoui A, Colom A, Braniste V, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil. 2014;26:510–520. doi:10.1111/nmo.12295
   PubMed Web of Science ®Google Scholar
• Feng C, Wang LJ, Li ZZ. The changes of intestinal microbiota affect the expression of brain-derived neurotropic factor in rat hippocampus. Chin J Microecol. 2015;27:10–13.
   Google Scholar
• Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16:448–458. doi:10.1002/mds.1090
   PubMed Web of Science ®Google Scholar
• Dodel DRC, Berger K, Oertel WH. Health-related quality of life and healthcare utilisation in patients with Parkinson’s disease. Pharmaco Econ. 2001;19:1013–1038. doi:10.2165/00019053-200119100-00004
   PubMed Web of Science ®Google Scholar
• Tiklová K, Gillberg L, Volakakis N, et al. Disease duration influences gene expression in neuromelanin-positive cells from Parkinson’s disease patients. Front Mol Neurosci. 2021;14:763777. doi:10.3389/fnmol.2021.763777
   Web of Science ®Google Scholar
• Jaunarajs KE, George JA, Bishop C. L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson’s disease. Neuroscience. 2012;218:243–256. doi:10.1016/j.neuroscience.2012.05.052
   Web of Science ®Google Scholar
• Michel E, Philippe DD, Li Q, et al. Widespread monoaminergic dysregulation of both motor and non-motor circuits in parkinsonism and dyskinesia. Cerebral Cortex. 2015;25:2783–2792. doi:10.1093/cercor/bhu076
   Web of Science ®Google Scholar
• Engevik MA, Luck B, Visuthranukul C, et al. Human-derived bifidobacterium dentium modulates the mammalian serotonergic system and gut-brain axis. Cell Mol Gastroenterol Hepatol. 2021;11(1):221–248. doi:10.1016/j.jcmgh.2020.08.002
   Web of Science ®Google Scholar
• Gough NR. Microbes message gut secretory cells. Sci Signal. 2015;8(373):ec101–ec101.
   Google Scholar
• Luo J, Wang T, Shan L, et al. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci. 2014;57:327–335. doi:10.1007/s11427-014-4615-4
   PubMed Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;163:256–258. doi:10.1016/j.cell.2015.09.017
   Web of Science ®Google Scholar
• Boelens Keun JT, Arnoldussen IA, Vriend C, et al. Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson’s disease: a systematic review. Adv Nutr. 2021;12(6):2265–2287. doi:10.1093/advances/nmab060
   PubMed Web of Science ®Google Scholar
• Chen SY, Xiao SJ, Lin YN, et al. Clinical efficacy and transcriptomic analysis of Congrong Shujing granules in patients with Parkinson’s disease and syndrome of Shen (Kidney) essence deficiency. Chin J Integr Med. 2020;26(6):412–419. doi:10.1007/s11655-020-3080-0
   Web of Science ®Google Scholar
• Li YQ, Wun XJ. Flavonoids from medicinal plants in prevention and treatment of Parkinson disease: advances and prospection on pharmacology. Chin J Pharmacol Toxicol. 2016;30:1125–1135.
   Google Scholar
• Blanchet J, Longpré F, Bureau G, et al. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1243–1250. doi:10.1016/j.pnpbp.2008.03.024
   PubMed Web of Science ®Google Scholar
• Mu X, He GR, Yuan X, et al. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav. 2011;98:286–291. doi:10.1016/j.pbb.2011.01.011
   PubMed Web of Science ®Google Scholar
• Xu CL, Qu R, Jin Z, et al. Neuroprotective effects of madecassoside in early stage of Parkinson’s disease induced by MPTP in rats. Fitoterapia. 2013;90:112–118. doi:10.1016/j.fitote.2013.07.009
   PubMed Web of Science ®Google Scholar
• Zhang S, Shao SY, Song XY, et al. Protective effects of Forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity. Neurotoxicology. 2016;52:72–83. doi:10.1016/j.neuro.2015.09.009
   PubMed Web of Science ®Google Scholar
• Yang MH. Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease: a multicenter, randomized, double-blind and placebo-controlled trial. J Chin Integr Med. 2010;8:231–237. doi:10.3736/jcim20100306
   Google Scholar
• Pan W, Kwak S, Li G, et al. Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson’s disease. Chin Med. 2013;8:14. doi:10.1186/1749-8546-8-14
   PubMed Web of Science ®Google Scholar
• Gu C, Shen T, An H, et al. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson’s disease dementia. Neurosci Lett. 2015;606:13–17. doi:10.1016/j.neulet.2015.08.019
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie CL, Lu L, et al. Chinese herbal medicine paratherapy for Parkinson’s disease: a meta-analysis of 19 randomized controlled trials. Evid Based Complement Altern Med. 2012;2012:534861.
   Web of Science ®Google Scholar
• Zhang G, Xiong N, Zhang Z, et al. Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson’s disease: a systematic review and meta-analysis. PLoS One. 2015;10:e0118498. doi:10.1371/journal.pone.0118498
   Web of Science ®Google Scholar
• Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson’s disease. Mov Disord. 2014;29:976–979. doi:10.1002/mds.25882
   PubMed Web of Science ®Google Scholar
• Liu JM, Wang FY, Liu SZ, et al. Sodium butyrate exerts protective effect against Parkinson’s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci. 2017;381:176–181. doi:10.1016/j.jns.2017.08.3235
   PubMed Web of Science ®Google Scholar
• Gresse R, Chau cheyras-Durand F, Garrido JJ, et al. Pathogen challenge and dietary shift alter microbiota composition and activity in a mucin-associated in vitro model of the Piglet Colon (MPigut-IVM) simulating weaning transition. Front Microbiol. 2021;12:703421. doi:10.3389/fmicb.2021.703421
   Web of Science ®Google Scholar
• Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365–1371. doi:10.1038/nm1511
   PubMed Web of Science ®Google Scholar
• Scheperjans F, Aho V, Pereira PAB, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2014;30:350–358. doi:10.1002/mds.26069
   Web of Science ®Google Scholar
• Forsyth CB, Shannon KM, Kordower JH, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS One. 2011;6:e28032. doi:10.1371/journal.pone.0028032
   PubMed Web of Science ®Google Scholar
• Ding Y, Yan YM, Peng YJ, et al. In vitro digestion under simulated saliva, gastric and small intestinal conditions and fermentation by human gut microbiota of polysaccharides from the fruits of Lycium barbarum. Int J Biol Macromol. 2018;125:751–760. doi:10.1016/j.ijbiomac.2018.12.081
   Web of Science ®Google Scholar
• Hu AL, Song S, Li Y, et al. Mercury sulfide-containing Hua-Feng-Dan and 70W (Rannasangpei) protect against LPS plus MPTP-induced neurotoxicity and disturbance of gut microbiota in mice. J Ethnopharmacol. 2020;254:112674. doi:10.1016/j.jep.2020.112674
   Web of Science ®Google Scholar
• Rey FE, Faith JJ, Bain J, et al. Dissecting the in vivo metabolic potential of two human gut acetogens. J Biol Chem. 2010;285(29):22082–22090. doi:10.1074/jbc.M110.117713
   PubMed Web of Science ®Google Scholar
• Bordin M, D’Atri F, Guillemot L, et al. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res. 2004;2(12):692–701. doi:10.1158/1541-7786.692.2.12
   PubMed Web of Science ®Google Scholar
• Fu SP, Wang JF, Xue WJ, et al. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms. J Neuroinflammation. 2015;12:1–14. doi:10.1186/s12974-014-0230-3
   Web of Science ®Google Scholar
• Unger MM, Spiegel J, Dillmann KU, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72. doi:10.1016/j.parkreldis.2016.08.019
   PubMed Web of Science ®Google Scholar
• He QL, Han CP, Huang L, et al. Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation. J Cell Mol Med. 2020;24:9349–9361. doi:10.1111/jcmm.15586
   Web of Science ®Google Scholar
• Wang LL, Guo HH, Huang S, et al. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction. J Chromatogr B. 2017;1057:70–80. doi:10.1016/j.jchromb.2017.05.004
   Web of Science ®Google Scholar
• Liu J, Yue SJ, Yang ZR, et al. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. Pharmacol Res. 2018;134:40–50. doi:10.1016/j.phrs.2018.05.012
   PubMed Web of Science ®Google Scholar
• Xiao SW, Zhang ZM, Chen MJ, et al. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism. J Ethnopharmacol. 2019;241:112032. doi:10.1016/j.jep.2019.112032
   PubMed Web of Science ®Google Scholar
• Mu C, Yang Y, Luo Z, et al. The colonic microbiome and epithelial transcriptome are altered in rats fed a high-protein diet compared with a normal-protein diet. J Nutr. 2016;146(3):474–483. doi:10.3945/jn.115.223990
   PubMed Web of Science ®Google Scholar
• Nagashima K, Sawa S, Nitta T, et al. Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat Immunol. 2017;18:675–682. doi:10.1038/ni.3732
   PubMed Web of Science ®Google Scholar
• Burcelin R. Gut microbiota and immune crosstalk in metabolic disease. Mol Metabol. 2016;5:771–781. doi:10.1016/j.molmet.2016.05.016
   PubMed Web of Science ®Google Scholar
• Chen YH, Qi BQ, Xu WF, et al. Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson’s disease. Mol Med Rep. 2015;12:6105–6111. doi:10.3892/mmr.2015.4136
   PubMed Web of Science ®Google Scholar
• Reynolds AD, Stone DK, Mosley RL, et al. Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. J Proteome Res. 2009;8:3497–3511. doi:10.1021/pr9001614
   PubMed Web of Science ®Google Scholar
• Liu J, Gong N, Huang X, et al. Neuromodulatory activities of CD4 + CD25 + regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol. 2009;182(6):3855–3865. doi:10.4049/jimmunol.0803330
   Web of Science ®Google Scholar
• Liu Z, Huang Y, Cao BB, et al. Th17 cells induce dopaminergic neuronal death via LFA-1/ICAM-1 interaction in a mouse model of Parkinson’s disease. Mol Neurobiol. 2017;54:7762–7776. doi:10.1007/s12035-016-0249-9
   Web of Science ®Google Scholar
• Saunders JAH, Estes KA, Kosloski LM, et al. CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease. J Neuroimmune Pharmacol. 2012;7:927–938. doi:10.1007/s11481-012-9402-z
   PubMed Web of Science ®Google Scholar
• Garidou L, Pomié C, Klopp P, et al. The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease. Cell Metab. 2015;22:100–112. doi:10.1016/j.cmet.2015.06.001
   PubMed Web of Science ®Google Scholar
• Chudnovskiy A, Mortha A, Kana V, et al. Host-protozoan interactions protect from mucosal infections through activation of the inflammasome. Cell. 2016;167(2):444–456. doi:10.1016/j.cell.2016.08.076
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337–341. doi:10.1126/science.1198469
   PubMed Web of Science ®Google Scholar
• Zhou RR, He D, Xie J, et al. The synergistic effects of polysaccharides and ginsenosides from American Ginseng (L.) ameliorating cyclophosphamide-induced intestinal immune disorders and gut barrier dysfunctions based on microbiome-metabolomics analysis. Front Immunol. 2021;12:665901. doi:10.3389/fimmu.2021.665901
   Web of Science ®Google Scholar
• González-Quilen C, Grau-Bové C, Jorba-Martín R, et al. Protective properties of grape-seed proanthocyanidins in human ex vivo acute colonic dysfunction induced by dextran sodium sulfate. Eur J Nutr. 2021;60:79–88. doi:10.1007/s00394-020-02222-3
   Web of Science ®Google Scholar
• Song X, Li J, Wang Y, et al. Clematichinenoside AR ameliorated spontaneous colitis in Il-10 mice associated with improving the intestinal barrier function and abnormal immune responses. Life Sci. 2019;239:117021. doi:10.1016/j.lfs.2019.117021
   Web of Science ®Google Scholar
• Yin N, Wang Y, Lu X, et al. hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway. Stem Cell Res Ther. 2018;9:37. doi:10.1186/s13287-018-0772-x
   PubMed Web of Science ®Google Scholar
• Zheng Q, Diao S, Wang Q, et al. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway. J Cell Mol Med. 2019;23:357–369. doi:10.1111/jcmm.13938
   Web of Science ®Google Scholar
• Xie SZ, Shang ZZ, Li QM, et al. Dendrobium huoshanense polysaccharide regulates intestinal lamina propria immune response by stimulation of intestinal epithelial cells via toll-like receptor 4. Carbohydr Polym. 2019;222:115028. doi:10.1016/j.carbpol.2019.115028
   Web of Science ®Google Scholar
• Sjolund K, Sanden G, Håkanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology. 1983;85:1120–1130. doi:10.1016/S0016-5085(83)80080-8
   PubMed Web of Science ®Google Scholar
• Ahlman H, Nilsson O. The gut as the largest endocrine organ in the body. Ann Oncol. 2001;12:S63–S68. doi:10.1093/annonc/12.suppl_2.S63
   Web of Science ®Google Scholar
• Bohórquez DV, Samsa LA, Andrew R, et al. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS One. 2014;9:e89881. doi:10.1371/journal.pone.0089881
   PubMed Web of Science ®Google Scholar
• Parthsarathy V, Hölscher C. The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain. Eur J Pharmacol. 2013;700:42–50. doi:10.1016/j.ejphar.2012.12.012
   PubMed Web of Science ®Google Scholar
• Bułdak Ł, Machnik G, Skudrzyk E, Bołdys A, Okopień B. The impact of exenatide (a GLP‑1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions. Exp Ther Med. 2019;17:2861–2869.
   PubMed Web of Science ®Google Scholar
• Andrews ZB, Erion D, Beiler R, et al. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci. 2009;29:14057. doi:10.1523/JNEUROSCI.3890-09.2009
   PubMed Web of Science ®Google Scholar
• Wang H, Dou S, Zhu J, et al. Ghrelin protects dopaminergic neurons against MPTP neurotoxicity through promoting autophagy and inhibiting endoplasmic reticulum mediated apoptosis. Brain Res. 2020;1746:147023. doi:10.1016/j.brainres.2020.147023
   Web of Science ®Google Scholar
• Nakamura T, Suzuki M, Okada A, et al. Association of leptin with orthostatic blood pressure changes in Parkinson’s disease. Mov Disorders. 2016;31(9):1–5. doi:10.1002/mds.26678
   Web of Science ®Google Scholar
• Cammisotto PG, Renaud C, Gingras D, Delvin E, Levy E, Bendayan M. Endocrine and exocrine secretion of leptin by the gastric mucosa. J Histochem Cytochem. 2005;53:851–860. doi:10.1369/jhc.5A6620.2005
   PubMed Web of Science ®Google Scholar
• Arora T, Akrami R, Pais R, et al. OPEN microbial regulation of the L cell transcriptome. Sci Rep. 2018;8. doi:10.1038/s41598-017-18079-2
   Web of Science ®Google Scholar
• Frye RE, Rose S, Slattery J, et al. Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome. Microb Ecol Health Dis. 2015;26:27458. doi:10.3402/mehd.v26.27458
   PubMedGoogle Scholar
• Hua M, Fan M, Li Z, et al. Ginseng soluble dietary fiber can regulate the intestinal flora structure, promote colon health, affect appetite and glucolipid metabolism in rats. J Funct Foods. 2021;83:104534. doi:10.1016/j.jff.2021.104534
   Web of Science ®Google Scholar
• Fu J, Wang Y, Tan S, et al. Effects of banana resistant starch on the biochemical indexes and intestinal flora of obese rats induced by a high-fat diet and their correlation analysis. Front Bioeng Biotechnol. 2021;9:575724. doi:10.3389/fbioe.2021.575724
   PubMed Web of Science ®Google Scholar
• Liu SN, Liu Q, Li CN, et al. Innovative hypoglycemic traditional Chinese medicine Sangzhi alkaloids regulating intestinal-pancreatic islet axis and its mechanism. Chin J Pharmacol Toxicol. 2019;33:36–37.
   Google Scholar
• Zhang XY, Chao J, Wang HT, et al. Effect of Shenqi compound on intestinal microflora and blood glucose fluctuations in diabetic GK rats. Chin Archiv Trad Chin Med. 2019;33:36–37.
   Google Scholar
• Shen RL, Zhang WL, Dong JL, et al. Sorghum resistant starch reduces adiposity in high-fat diet-induced overweight and obese rats via mechanisms involving adipokines and intestinal flora. Food Agric Immunol. 2015;26:120–130. doi:10.1080/09540105.2013.876976
   Web of Science ®Google Scholar
• Xu Y, Wang N, Tan HY, et al. Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin-mediated AMPKα/STAT3 signaling in diet-induced obesit. Theranostics. 2020;10:11302–11323. doi:10.7150/thno.47746
   PubMed Web of Science ®Google Scholar
• Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631–659.
   PubMed Web of Science ®Google Scholar
• Krug SM, Schulzke JD, Fromm M. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–176. doi:10.1016/j.semcdb.2014.09.002
   PubMed Web of Science ®Google Scholar
• Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb Perspect Biol. 2018;10(1):a029314–a029330. doi:10.1101/cshperspect.a029314
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. SnapShot: epithelial Tight Junctions. Cell. 2014;157:992. doi:10.1016/j.cell.2014.04.027
   PubMed Web of Science ®Google Scholar
• Chelpin MVE, Thomas VJ. Targets and mechanisms in prevention of Parkinson’s disease through immunomodulatory treatments. Scand J Immunol. 2017;85:321–330. doi:10.1111/sji.12542
   Web of Science ®Google Scholar
• Stecher B, Robbiani R, Walker AW, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007;5(10):2177–2189. doi:10.1371/journal.pbio.0050244
   PubMed Web of Science ®Google Scholar
• Kelly LP, Carvey PM, Keshavarzian A, et al. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease. Mov Disorders. 2013;29:999–1009. doi:10.1002/mds.25736
   Web of Science ®Google Scholar
• Clairembault T, Leclair-Visonneau L, Coron E, et al. Structural alterations of the intestinal epithelial barrier in Park s disease. Inson Acta Neuropathol Commun. 2015;3:12. doi:10.1186/s40478-015-0196-0
   PubMed Web of Science ®Google Scholar
• Zhang BX, Yue RS, Chen Y, et al. The herbal medicine Scutellaria-coptis alleviates intestinal mucosal barrier damage in diabetic rats by inhibiting inflammation and modulating the gut microbiota. Evid Based Complement Altern Med. 2020;2020:4568629. doi:10.1155/2020/4568629
   Web of Science ®Google Scholar
• Sun T, Liang H, Xue M, et al. Protective effect and mechanism of fucoidan on intestinal mucosal barrier function in NOD mice. Food Agric Immunol. 2020;31:922–936. doi:10.1080/09540105.2020.1789071
   Web of Science ®Google Scholar
• Yuan ZW, Yang LH, Zhang XS, et al. Huang-Lian-Jie-Du decoction ameliorates acute ulcerative colitis in mice via regulating NF-κB and Nrf2 signaling pathways and enhancing intestinal barrier function. Front Pharmacol. 2019;10:1354. doi:10.3389/fphar.2019.01354
   PubMed Web of Science ®Google Scholar
• Gu JF, Su SL, Guo JM, et al. The aerial parts of Salvia miltiorrhiza Bge. strengthen intestinal barrier and modulate gut microbiota imbalance in streptozocin-induced diabetic mice. J Funct Foods. 2017;36:362–374. doi:10.1016/j.jff.2017.06.010
   Web of Science ®Google Scholar
• Tuganbaev T, Mor U, Bashiardes S, et al. Diet diurnally regulates small intestinal microbiome-epithelial-immune homeostasis and enteritis. Cell. 2020;182(6):1441–1459.e21. doi:10.1016/j.cell.2020.08.027
   PubMed Web of Science ®Google Scholar
• Wu H, Xie S, Miao J, et al. Lactobacillus reuteri maintains intestinal epithelial regeneration and repairs damaged intestinal mucosa. Gut Microbes. 2020;11(4):997–1014. doi:10.1080/19490976.2020.1734423
   PubMed Web of Science ®Google Scholar
• Longhena F, Faustini G, Spillantini M, et al. Living in promiscuity: the multiple partners of alpha-synuclein at the synapse in physiology and pathology. Int J Mol Sci. 2019;20:141. doi:10.3390/ijms20010141
   Web of Science ®Google Scholar
• Zhang X, Wu D, Liang J, et al. Effects of Salvia miltiorrhizae on ICAM-1, TLR4, NF-kappa B and Bax proteins expression in multiple organs of rats with severe acute pancreatitis or obstructive jaundice. Inflammation. 2009;32:218–232. doi:10.1007/s10753-009-9124-4
   PubMed Web of Science ®Google Scholar
• Chen X, Hu Y, Cao Z, et al. Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol. 2018;9:2122. doi:10.3389/fimmu.2018.02122
   PubMed Web of Science ®Google Scholar
• Fyl A, Jing WA, Jh A, et al. Gastrodia remodels intestinal microflora to suppress inflammation in mice with early atherosclerosis. Int Immunopharmacol. 2021;96:107758. doi:10.1016/j.intimp.2021.107758
   Web of Science ®Google Scholar
• Gan Z, Wei W, Li Y, et al. Curcumin and resveratrol regulate intestinal bacteria and alleviate intestinal inflammation in weaned piglets. Molecules. 2019;24:1220. doi:10.3390/molecules24071220
   Web of Science ®Google Scholar